All Stories

  1. Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
  2. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
  3. Drug-induced ciliogenesis in pancreatic cancer cells is facilitated by the secreted ATP-purinergic receptor signaling pathway
  4. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
  5. Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
  6. The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy
  7. Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
  8. An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAFV600E inhibitor-resistant metastatic melanoma cells
  9. Orientation of Preclinical Research in Ovarian Cancer
  10. Trial watch: Dendritic cell-based anticancer immunotherapy
  11. Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
  12. Computed determination of the in vitro optimal chemocombinations of sphaeropsidin A with chemotherapeutic agents to combat melanomas
  13. Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
  14. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
  15. Biomimicry in cancer: When therapy-induced apoptosis meets infection-associated pathways!!
  16. Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death
  17. DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing
  18. Transplantation and Damage-Associated Molecular Patterns (DAMPs)
  19. Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
  20. Editorial: Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality
  21. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
  22. Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation
  23. Extracellular ATP and P2X7 receptor exert context-specific immunogenic effects after immunogenic cancer cell death
  24. Coordination of stress, Ca2+, and immunogenic signaling pathways by PERK at the endoplasmic reticulum
  25. Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality
  26. Melphalan, Antimelanoma Immunity, and Inflammation--Response
  27. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
  28. Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
  29. Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis
  30. Autophagy, a major adaptation pathway shaping cancer cell death and anticancer immunity responses following photodynamic therapy
  31. The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: From sensor to the plasma membrane and beyond
  32. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
  33. Melanoma targeting with the loco-regional chemotherapeutic, Melphalan: From cell death to immunotherapeutic efficacy
  34. Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface-Associated Calreticulin
  35. Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells
  36. Immunogenic cell death
  37. Classification of current anticancer immunotherapies
  38. Autophagy Induced by Photodynamic Therapy (PDT): Shaping Resistance Against Cell Death and Anti-Tumor Immunity
  39. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
  40. Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
  41. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
  42. Citrullinated Glucose-Regulated Protein 78 Is an Autoantigen in Type 1 Diabetes
  43. Consensus guidelines for the detection of immunogenic cell death
  44. BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton
  45. ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses
  46. Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene, LAMP2A
  47. Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity
  48. Cell Death and PDT-Based Photooxidative (Phox) Stress
  49. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
  50. Inducers of immunogenic cancer cell death
  51. Pro-apoptotic signaling induced by photo-oxidative ER stress is amplified by Noxa, not Bim
  52. Autophagy: shaping the tumor microenvironment and therapeutic response
  53. Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?
  54. Danger signalling during cancer cell death: origins, plasticity and regulation
  55. Targeting ER stress induced apoptosis and inflammation in cancer
  56. Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
  57. Immunogenic cell death and DAMPs in cancer therapy
  58. ER stress-induced inflammation: does it aid or impede disease progression?
  59. The emergence of phox-ER stress induced immunogenic apoptosis
  60. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress
  61. In Vitro Studies on Erythrosine-Based Photodynamic Therapy of Malignant and Pre-Malignant Oral Epithelial Cells
  62. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
  63. Contribution of ER Stress to Immunogenic Cancer Cell Death
  64. ER Stress and Inflammation
  65. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin
  66. DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown
  67. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation
  68. Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity
  69. Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation
  70. Efficient in silico designing of oligonucleotides for artificial gene synthesis
  71. Antimicrobial activity of skin secretions isolated from Indian toad, Bufo melanostictus Schneider 1799
  72. Studying effect of hypergravity on cleavage timings in developing embryos of Limnaea